Drug General Information
Drug ID	D04YHZ
Former ID	DNC012036
Drug Name	3-Methoxycarbonyl-2-methyl-9H-beta-carbolin-2-ium
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[551248]
Structure		Download 2D MOL 3D MOL
Formula	C14H13N2O2+
Canonical SMILES	C[N+]1=C(C=C2C3=CC=CC=C3NC2=C1)C(=O)OC
InChI	1S/C14H12N2O2/c1-16-8-12-10(7-13(16)14(17)18-2)9-5-3-4-6-11(9)15-12/h3-8H,1-2H3/p+1
InChIKey	UUMQQVGTICTWCW-UHFFFAOYSA-O
PubChem Compound ID	15630152
Target and Pathway
Target(s)	Gamma-aminobutyric acid receptor subunit alpha-1	Target Info	Inhibitor	[551248]
	Gamma-aminobutyric acid receptor	Target Info	Inhibitor	[551248]
KEGG Pathway	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
	GABAergic synapse
	Morphine addiction
	Nicotine addiction
Reactome	Ligand-gated ion channel transport
	GABA A receptor activation
WikiPathways	SIDS Susceptibility Pathways
	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
	Iron uptake and transport
References
Ref 551248	N-2 methylated quaternary derivatives of beta-carboline-3-carboxylates inhibit acetylcholinesterase in vitroO, Bioorg. Med. Chem. Lett. 3(12):2831-2836 (1993).
Ref 551248	N-2 methylated quaternary derivatives of beta-carboline-3-carboxylates inhibit acetylcholinesterase in vitroO, Bioorg. Med. Chem. Lett. 3(12):2831-2836 (1993).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.